Health-Related Quality of Life in Patients With Barrett's Esophagus: A Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 6, 2009, Pages 613-623

  Crockett, Seth D ^a   Lippmann, Quinn K ^a   Dellon, Evan S ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ANXIETY; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL FEATURE; DEPRESSION; DYSPHASIA; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MEDICAL LITERATURE; MENTAL STRESS; PHOTODYNAMIC THERAPY; PUBLICATION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SHORT FORM 36; SYSTEMATIC REVIEW;

BARRETT ESOPHAGUS; HUMANS; QUALITY OF LIFE;

EID: 66149181765     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.02.024     Document Type: Review

References (65)

1. Barrett N.R. Chronic peptic ulcer of the oesophagus and "oesophagitis.". Br J Surg 38 (1950) 175-182
2. Allison P.R., and Johnstone A.S. The oesophagus lined with gastric mucous membrane. Thorax 8 (1953) 87-101
3. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
4. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
5. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
6. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
7. Shaker R., Castell D.O., Schoenfeld P.S., et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 98 (2003) 1487-1493
8. Csendes A., Smok G., Burdiles P., et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 13 (2000) 5-11
9. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
10. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
11. Winters Jr. C., Spurling T.J., Chobanian S.J., et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 (1987) 118-124
12. Eisen G.M., Locke III G.R., and Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol 94 (1999) 2017-2021
13. Moyer C.A., and Fendrick A.M. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis 16 (1998) 315-324
14. Yacavone R.F., Locke III G.R., Provenzale D.T., et al. Quality of life measurement in gastroenterology: what is available?. Am J Gastroenterol 96 (2001) 285-297
15. Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scand J Gastroenterol Suppl 199 (1993) 18-21
16. Kamolz T., Pointner R., and Velanovich V. The impact of gastroesophageal reflux disease on quality of life. Surg Endosc 17 (2003) 1193-1199
17. Liker H., Hungin P., and Wiklund I. Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract 18 (2005) 393-400
18. Ofman J.J. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98 (2003) S8-S14
19. Wiklund I., and Talley N.J. Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoeconomics Outcomes Res 3 (2003) 341-350
20. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 22 (2004) 108-114
21. Cook D.J., Sackett D.L., and Spitzer W.O. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 48 (1995) 167-171
22. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
23. Guyatt G.H., Osoba D., Wu A.W., et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77 (2002) 371-383
24. Spiegel B.M., Younossi Z.M., Hays R.D., et al. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 41 (2005) 790-800
25. King M.T., and Fayers P.M. Making quality-of-life results more meaningful for clinicians. Lancet 371 (2008) 709-710
26. McHorney C.A., Ware Jr. J.E., and Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31 (1993) 247-263
27. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
28. Eypasch E., Williams J.I., Wood-Dauphinee S., et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82 (1995) 216-222
29. Wiklund I.K., Junghard O., Grace E., et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 583 (1998) 41-49
30. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20 (2007) 130-134
31. Derogatis L.R. SCL-90-R: administration, scoring and procedure manual (1983), Clinical Psychometrics Research, Baltimore, MD
32. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
33. Kulig M., Leodolter A., Vieth M., et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 18 (2003) 767-776
34. Eloubeidi M.A., and Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 95 (2000) 1881-1887
35. Eloubeidi M., Uslick B., and Provenzale D. Health related quality of life (HRQL) in patients with Barrett's esophagus. Gastroenterology 112 (1997) A14
36. Gerson L.B., Ullah N., Hastie T., et al. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?. Gastrointest Endosc 65 (2007) 16-25
37. Lippmann Q.K., Madanick R.D., Spacek M., et al. Psychological well-being and quality of life (QOL) in Barrett's esophagus (BE) compared to gastroesophageal reflux disease (GERD). Gastroenterology 134 (2008) A322
38. Kamolz T., Granderath F., and Pointner R. Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett's esophagus. Surg Endosc 17 (2003) 880-885
39. Markus P.M., Horstmann O., Kley C., et al. Laparoscopic fundoplication. Surg Endosc 16 (2002) 48-53
40. Fisher D., Jeffreys A., Bosworth H., et al. Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol 97 (2002) 2193-2200
41. Hur C., Wittenberg E., Nishioka N.S., et al. Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes 4 (2006) 45
42. Gerson L.B., Ullah N., Hastie T., et al. Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol 100 (2005) 524-533
43. Gerson L.B., Shetler K., and Triadafilopoulos G. Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Dig Liver Dis 37 (2005) 651-658
44. Kruijshaar M.E., Kerkhof M., Siersema P.D., et al. The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy 38 (2006) 873-878
45. Amonkar M.M., Kalsekar I.D., and Boyer J.G. The economic burden of Barrett's esophagus in a Medicaid population. Ann Pharmacother 36 (2002) 605-611
46. Eloubeidi M.A., Homan R.K., Martz M.D., et al. A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting. Am J Gastroenterol 94 (1999) 2033-2036
47. Willich S.N., Nocon M., Kulig M., et al. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther 23 (2006) 371-376
48. Shaheen N.J., Dulai G.S., Ascher B., et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 100 (2005) 577-580
49. Shaheen N.J., Green B., Medapalli R.K., et al. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology 129 (2005) 429-436
50. Kruijshaar M.E., Siersema P.D., Janssens A.C., et al. Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest Endosc 65 (2007) 26-30
51. Rosmolen W., Boer K., Van Ianschot J., et al. Fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett's esophagus. Gastroenterology 132 (2007) A474-A475
52. Shaheen N.J., Wolfsen H.C., Hawes R.H., et al. Impact of Barrett's esophagus containing dysplasia on patient quality of life: interim results of a randomized, sham-controlled trial of Radiofrequency ablation (AIM dysplasia trial). Gastroenterology 134 (2008) A323
53. Rodger A.J., Jolley D., Thompson S.C., et al. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30 (1999) 1299-1301
54. Mena-Martin F.J., Martin-Escudero J.C., Simal-Blanco F., et al. Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens 21 (2003) 1283-1289
55. Rubenstein J.H., and Inadomi J.M. Defining a clinically significant adverse impact of diagnosing Barrett's esophagus. J Clin Gastroenterol 40 (2006) 109-115
56. Essink-Bot M.L., Kruijshaar M.E., Bac D.J., et al. Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groups. Qual Life Res 16 (2007) 1309-1318
57. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287 (2002) 1972-1981
58. Anderson L.A., Murray L.J., Murphy S.J., et al. Mortality in Barrett's oesophagus: results from a population based study. Gut 52 (2003) 1081-1084
59. Eckardt V.F., Kanzler G., and Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 111 (2001) 33-37
60. Loffeld R.J. Young patients with Barrett's oesophagus experience less reflux complaints. Digestion 64 (2001) 151-154
61. Madisch A., Miehlke S., Sell S., et al. Patients with Barretts esophagus experience less reflux complaints. Gastroenterology 130 (2006) A263
62. Ware J., Kosinski M., and Dewey J. How to score version 2 of the SF-36 Health Survey (2000), QualityMetric Incorporated, Lincoln, RI
63. Derogatis L.R., Rickels K., and Rock A.F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 128 (1976) 280-289
64. Ware J.K.M., and Gandek B. SF-36 health survey: manual & interpretation guide (2000), QualityMetric Incorporated, Lincoln, RI
65. Dellon E.S., and Shaheen N.J. Barrett's esophagus and the costs of "doing something.". Gastrointest Endosc 65 (1976) 31-35